MARKET

OSRH

OSRH

OSR Holdings, Inc.
NASDAQ
0.6510
+0.0782
+13.65%
After Hours: 0.6010 -0.05 -7.68% 19:49 12/19 EST
OPEN
0.6120
PREV CLOSE
0.5728
HIGH
0.6892
LOW
0.5800
VOLUME
950.71K
TURNOVER
--
52 WEEK HIGH
12.54
52 WEEK LOW
0.4530
MARKET CAP
16.71M
P/E (TTM)
-0.3758
1D
5D
1M
3M
1Y
5Y
1D
OSR Holdings Announces Woori IO Shareholders Approve Proposed Acquisition By OSR
Benzinga · 1d ago
Woori IO Shareholders Approve Share Exchange with OSR Holdings
Reuters · 1d ago
WOORI IO SHAREHOLDERS APPROVE SHARE EXCHANGE TO BECOME WHOLLY-OWNED SUBSIDIARY OF OSR HOLDINGS
Reuters · 1d ago
Weekly Report: what happened at OSRH last week (1208-1212)?
Weekly Report · 5d ago
Weekly Report: what happened at OSRH last week (1201-1205)?
Weekly Report · 12/08 10:20
Emerging Growth Research Reaffirms Buy on OSR Holdings With $10 Price Target
Reuters · 12/04 20:19
BRIEF-OSR Holdings Says Vaximm AG Shortens Exclusivity Period With BCM Europe To Three Months
Reuters · 12/02 18:22
Vaximm updates term sheet with BCM Europe to shorten exclusivity period
TipRanks · 12/02 15:06
More
About OSRH
OSR Holdings, Inc. is a global healthcare company, dedicated to advancing healthcare outcomes and improving the quality of life for people and their families. The Company is focused on building and developing a portfolio of transformative therapies and healthcare solutions. The Company's operating businesses (through its three wholly owned subsidiaries) include developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases and neurovascular intervention medical device and systems distribution in Korea. The Company’s subsidiary, Vaximm’s flagship asset, VXM01, is a late clinical-stage (NCT037500701) immuno-oncology candidate for glioblastoma. Vaximm has three clinical and pre-clinical drug candidates targeting diseases ranging from glioblastoma to gastrointestinal stromal tumor to ocular diseases. The Company has operations in Europe and South Korea.

Webull offers OSR Holdings Inc stock information, including NASDAQ: OSRH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OSRH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OSRH stock methods without spending real money on the virtual paper trading platform.